Bristol-Myers Squibb and Halozyme Enter Global Collaboration and License Agreement
Bristol-Myers Squibb Company and Halozyme Therapeutics, Inc. announced a global collaboration and license agreement to develop subcutaneously administered Bristol-Myers Squibb…
Read More...
Read More...
